When does DNA X INC (SONM) report earnings?
DNA X INC (SONM) will report earnings on 2026-03-30, after the market close.
DNA X INC (SONM) Forecast, Price Target & Analyst Ratings
NASDAQ:SONM • US83548F4081
Current stock price
3.35 USD
-0.32 (-8.72%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DNA X INC (SONM).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.62
- Revenue Estimate
- 42.03M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $3.35 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
SONM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SONM.
In the previous month the buy percentage consensus was at a similar level.
SONM was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.62
- Revenue Estimate
- 42.03M
- Revenue Q2Q
- 180.50%
- EPS Q2Q
- 252.50%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
SONM is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is 0.62 USD and the consensus revenue estimate is 42.03M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 69.8M 27.84% | 93.632M 34.14% | 58.298M -37.74% | 132.73M 127.68% | |
| EBITDA YoY % growth | -11.92M 66.77% | 2.719M 122.81% | -26.104M -1,060.06% | 8.028M 130.75% | |
| EBIT YoY % growth | -14.3M 62.37% | 513K 103.59% | -29.661M -5,881.87% | 4.581M 115.44% | |
| Operating Margin | -20.49% | 0.55% | -50.88% | 3.45% | |
| EPS YoY % growth | N/A | N/A | N/A -143.75% | 0.86 126.67% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.62 252.50% |
| Revenue Q2Q % growth | 42.03M 180.50% |
| EBITDA Q2Q % growth | 4.065M 122.86% |
| EBIT Q2Q % growth | 3.203M 115.01% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
DNA X INC / SONM Forecast FAQ
Can you provide the consensus estimates for DNA X INC next earnings?
The consensus EPS estimate for the next earnings of DNA X INC (SONM) is 0.62 USD and the consensus revenue estimate is 42.03M USD.
Can you provide the consensus rating for DNA X INC stock?
The consensus rating for DNA X INC (SONM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.